Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Assess the Safety and Tolerability of Single Doses of REGN1500

NCT01749878 is registered in ClinicalTrials.gov with Regeneron Pharmaceuticals as lead sponsor.

NCT NCT01749878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01749878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Assess the Safety and Tolerability of Single Doses of REGN1500
Lead sponsor
Regeneron Pharmaceuticals
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2012
Completion date
January 31, 2016
Enrollment
99 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hypertriglyceridemia